Progress on the role of metabolic reprogramming in the occurrence of atrial fibrillation

doi:10.16352/j.issn.1001-6325.2023.11.1718

Abstract

Abstract: Metabolic re-programming is a biological process which promotes cell proliferation by changing the metabolic mode to meet the energy demand. Its occurrence can change the metabolic mode of sugar, amino acid and fatty acid. Atrial fibrillation is one of the common arrhythmia. By regulating the pathway related to metabolic reprogramming may effectively alleviate the symptoms of atrial fibrillation, reduce the susceptibility of atrial fibrillation and improve the quality of life of patients.

Key words: atrial fibrillation, metabolomics, metabolic reprogramme

CLC Number:

R541.7

MIAO Haozhen, TAO Lei, SONG Bingjie, ZHANG Qijun. Progress on the role of metabolic reprogramming in the occurrence of atrial fibrillation[J]. Basic & Clinical Medicine, 2023, 43(11): 1718-1722.

References 25

[1]	Hu B, Ge W, Wang Y, et al. Metabolomic and proteomic analyses of persistent valvular atrial fibrillation and non-valvular atrial fibrillation[J]. Front Genet, 2021,12:789485-789495.
[2]	McCauley MD, Hong L, Sridhar A, et al. Ion channel and structural remodeling in obesity-mediated atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2020,13:755-767.
[3]	Shiou YL, Lin HT, Ke LY, et al. Very low-density lipoproteins of metabolic syndrome modulates STIM1, suppresses store-operated calcium entry, and deranges myofilament proteins in atrial myocytes[J]. J Clin Med, 2019,8:881-895.
[4]	Lee HC, Shin SJ, Huang JK, et al. The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome[J]. Lipids Health Dis, 2020,19:210-221.
[5]	Harrison SL, Lane DA, Banach M, et al. Lipid levels, atrial fibrillation and the impact of age: results from the LIPIDOGRAM2015 study[J]. Atherosclerosis, 2020,312:16-22.
[6]	Poulet C, Sanchez-Alonso J, Swiatlowska P, et al. Junctophilin-2 tethers T-tubules and recruits functional L-type calcium channels to lipid rafts in adult cardiomyocytes[J]. Cardiovasc Res, 2021,117:149-161.
[7]	Tajik B, Tuomainen TP, Jarroch R, et al. Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: a report from the kuopio ischaemic heart disease risk factor study (KIHD)[J]. J Clin Lipidol, 2022,16:447-454.
[8]	Garg PK, Guan W, Nomura S, et al. Plasma omega-3 and omega-6 PUFA concentrations and risk of atrial fibrillation: the multi-ethnic study of atherosclerosis[J]. J Nutr, 2021;151:1479-1486.
[9]	Tu T, Li B, Li X, et al. Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation[J]. J Cardiol, 2022,79:194-201.
[10]	Tajik B, Tuomainen TP, Isanejad M, et al. Serum n-6 polyunsaturated fatty acids and risk of atrial fibrillation: the kuopio ischaemic heart disease risk factor study[J]. Eur J Nutr, 2022,61:1981-1989.
[11]	Zhang J, Zuo K, Fang C, et al. Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation[J]. BMC Genomics, 2021,22:634-644.
[12]	Zuo K, Fang C, Liu Z, et al. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling[J]. Int J Biol Sci, 2022,18:4219-4232.
[13]	Maria Z, Campolo AR, Scherlag BJ, et al. Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation[J]. Biochim Biophys Acta Mol Basis Dis, 2018,1864:987-996.
[14]	Maria Z, Campolo AR, Scherlag BJ, et al. Insulin treatment reduces susceptibility to atrial fibrillation in type 1 diabetic mice[J]. Front Cardiovasc Med, 2020,7:134-146.
[15]	Fu L, Rao F, Lian F, et al. Mechanism of electrical remodeling of atrial myocytes and its influence on susceptibility to atrial fibrillation in diabetic rats[J]. Life Sci, 2019,239:116903.doi:10.1016/j.Ifs.2019.116903.
[16]	Zheng DL, Wu QR, Zeng P, et al. Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice[J]. Aging Cell, 2022,21:e13734-e13746.
[17]	Bohne LJ, Jansen HJ, Daniel I, et al. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice[J]. Heart Rhythm, 2021,18:118-129.
[18]	Wu X, Liu Y, Tu D, et al. Role of NLRP3-inflammasome/caspase-1/galectin-3 pathway on atrial remodeling in diabetic rabbits[J]. J Cardiovasc Transl Res, 2020,13:731-740.
[19]	Wiersma M, van Marion DMS, Wust RCI, et al. Mitochondrial dysfunction underlies cardiomyocyte remodeling in experimental and clinical atrial fibrillation[J]. Cells, 2019,8:1202-1220.
[20]	Yuan M, Gong M, He J, et al. IP3R1/GRP75/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling[J]. Redox Biol, 2022,52:102289-102302.
[21]	Li J, Qi X, Ramos KS, et al. Disruption of sarcoplasmic reticulum-mitochondrial contacts underlies contractile dysfunction in experimental and human atrial fibrillation: a key role of mitofusin 2[J]. J Am Heart Assoc, 2022;11:e024478-e024496.
[22]	Lu Han AW, Qing Li, Zhen Xia, et al. Homocysteine-induced electrical remodeling via the mediation of IP3R1Nav1.5 signaling pathway[J]. Am J Transl Res, 2020,12:3822-3841.
[23]	Han L, Tang Y, Li S, et al. Protective mechanism of SIRT1 on hcy-induced atrial fibrosis mediated by TRPC3[J]. J Cell Mol Med, 2020,24:488-510.
[24]	Lu C, Liu C, Mei D, et al. Comprehensive metabolomic characterization of atrial fibrillation[J]. Front Cardiovasc Med, 2022,9:911845-11863.
[25]	Xie D, Xiong K, Su X, et al. Identification of an endogenous glutamatergic transmitter system controlling excitabi-lity and conductivity of atrial cardiomyocytes[J]. Cell Res, 2021;31:951-964.